top of page
The Professional Network for Healthcare Experts
Astellas signs option and licensing agreement with Audax Biosciences worth up to $1.34bn for cancer therapy DAX-044
Astellas secures an exclusive global option to license Audax Biosciences' investigational IL-12 fusion therapy DAX-044
nuaxia
Oct 292 min read
Roche signs Hansoh Pharma oncology ADC collaboration with more than $15 billion in potential milestones
Roche and Hansoh Pharma have signed a major oncology licensing agreement involving antibody-drug conjugates, with more than $15 billion in potential milestone payments.
nuaxia
Oct 202 min read
bottom of page